DV
Dividend Vision

SLGL — Sol Gel Technologies Ltd

Sol Gel Technologies Ltd (SLGL)

Total return is -37.9% over the past 8.5 years, 252.0 points behind SPY at 214.1%. Its deepest 1-year drawdown was 35.4%.

SLGL is an equity fund that holds Sol Gel Technologies Ltd, a specialty pharmaceutical company focused on dermatological treatments. The fund does not currently distribute dividends and carries no listed expense ratio or available asset under management data. This structure appeals primarily to growth-oriented investors seeking exposure to the pharmaceutical sector rather than income-focused dividend investors.

SLGL key facts

Asset type
Stock
Asset class
Equity
Inception date
02/01/2018
Last close
$84.69
Market cap
$259,946,128
Average volume
79400.0
Beta
1.126
Payout ratio
0.0
Forward P/E
9.3371
EPS
$-0.30